WGS
USDGeneDx Holdings Corp. Class A Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$134.910
Kõrge
$141.750
Madal
$134.000
Maht
0.68M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
4.0B
Tööstusharu
Diagnostics & Research
Riik
United States
Kauplemisstatistika
Keskmine maht
0.58M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Wells Fargo Maintains Equal-Weight on GeneDx Holdings, Raises Price Target to $140
Wells Fargo analyst Brandon Couillard maintains GeneDx Holdings with a Equal-Weight and raises the price target from $95 to $140.
Canaccord Genuity Maintains Buy on GeneDx Holdings, Raises Price Target to $160
Canaccord Genuity analyst Kyle Mikson maintains GeneDx Holdings with a Buy and raises the price target from $155 to $160.
Guggenheim Maintains Buy on GeneDx Holdings, Raises Price Target to $170
Guggenheim analyst Subbu Nambi maintains GeneDx Holdings with a Buy and raises the price target from $115 to $170.
BTIG Maintains Buy on GeneDx Holdings, Raises Price Target to $165
BTIG analyst Mark Massaro maintains GeneDx Holdings with a Buy and raises the price target from $140 to $165.
GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
Reported third quarter 2025 revenues of $116.7 million with 65% year-over-year growth in exome and genome test revenue Accelerated exome and genome volume growth to 33% year-over-year Expanded adjusted gross
GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims
Schubert Jonckheer & Kolbe LLP reminds GeneDx Holdings Corp. (NASDAQ: WGS) investors that the firm is investigating potential legal claims relating...
BTIG Maintains Buy on GeneDx Holdings, Raises Price Target to $140
BTIG analyst Mark Massaro maintains GeneDx Holdings with a Buy and raises the price target from $125 to $140.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.